These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 37680163)

  • 1. Terpenoids in Diabetic Nephropathy: Advances and Therapeutic Opportunities.
    Kaushik M; Kaushik A; Chaudhary J; Jain A
    Endocr Metab Immune Disord Drug Targets; 2024; 24(1):13-30. PubMed ID: 37680163
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Promising therapeutic mechanism for Chinese herbal medicine in ameliorating renal fibrosis in diabetic nephropathy.
    Wang S; Qin S; Cai B; Zhan J; Chen Q
    Front Endocrinol (Lausanne); 2023; 14():932649. PubMed ID: 37522131
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevated levels of renal and circulating Nop-7-associated 2 (NSA2) in rat and mouse models of diabetes, in mesangial cells in vitro and in patients with diabetic nephropathy.
    Shahni R; Gnudi L; King A; Jones P; Malik AN
    Diabetologia; 2012 Mar; 55(3):825-34. PubMed ID: 22095236
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proteomics and diabetic nephropathy.
    Merchant ML; Klein JB
    Curr Diab Rep; 2005 Dec; 5(6):464-9. PubMed ID: 16316599
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Perspective on the Impact of Advanced Glycation End Products in the Progression of Diabetic Nephropathy.
    Khanam A; Ahmad S; Husain A
    Curr Protein Pept Sci; 2023; 24(1):2-6. PubMed ID: 36366848
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of diabetic nephropathy: Recent progress and future perspective.
    Ahmad J
    Diabetes Metab Syndr; 2015; 9(4):343-58. PubMed ID: 25845297
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Renal endothelial protein C receptor expression and shedding during diabetic nephropathy.
    Lattenist L; Ochodnický P; Ahdi M; Claessen N; Leemans JC; Satchell SC; Florquin S; Gerdes VE; Roelofs JJ
    J Thromb Haemost; 2016 Jun; 14(6):1171-82. PubMed ID: 26990852
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diabetic Nephropathy: Significance of Determining Oxidative Stress and Opportunities for Antioxidant Therapies.
    Darenskaya M; Kolesnikov S; Semenova N; Kolesnikova L
    Int J Mol Sci; 2023 Aug; 24(15):. PubMed ID: 37569752
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Moringa oleifera Lam. seed extract protects kidney function in rats with diabetic nephropathy by increasing GSK-3β activity and activating the Nrf2/HO-1 pathway.
    Wen Y; Liu Y; Huang Q; Liu R; Liu J; Zhang F; Liu S; Jiang Y
    Phytomedicine; 2022 Jan; 95():153856. PubMed ID: 34856477
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early detection of diabetic nephropathy in patient with type 2 diabetes mellitus: A review of the literature.
    Thipsawat S
    Diab Vasc Dis Res; 2021; 18(6):14791641211058856. PubMed ID: 34791910
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ferroptosis: a new strategy for Chinese herbal medicine treatment of diabetic nephropathy.
    Wei M; Liu X; Tan Z; Tian X; Li M; Wei J
    Front Endocrinol (Lausanne); 2023; 14():1188003. PubMed ID: 37361521
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Role of Chemokines and Chemokine Receptors in Diabetic Nephropathy.
    Chang TT; Chen JW
    Int J Mol Sci; 2020 Apr; 21(9):. PubMed ID: 32365893
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diabetic Nephropathy: Pathogenesis to Cure.
    Kushwaha K; Kabra U; Dubey R; Gupta J
    Curr Drug Targets; 2022; 23(15):1418-1429. PubMed ID: 35993461
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protective effect of vanillin on diabetic nephropathy by decreasing advanced glycation end products in rats.
    Zabad IEM; Amin MN; El-Shishtawy MM
    Life Sci; 2019 Dec; 239():117088. PubMed ID: 31759039
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Advanced glycation end products (AGEs) increase renal lipid accumulation: a pathogenic factor of diabetic nephropathy (DN).
    Yuan Y; Sun H; Sun Z
    Lipids Health Dis; 2017 Jun; 16(1):126. PubMed ID: 28659153
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diabetic Nephropathy: An Overview.
    Sagoo MK; Gnudi L
    Methods Mol Biol; 2020; 2067():3-7. PubMed ID: 31701441
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of Diabetic Nephropathy in Patients Attending the Endocrine Department of Mymensingh Medical College Hospital.
    Islam MR; Sultana N; Sutradhar SR; Asaduzzaman M
    Mymensingh Med J; 2020 Jul; 29(3):530-538. PubMed ID: 32844790
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oxidative Stress in Diabetic Nephropathy with Early Chronic Kidney Disease.
    Miranda-Díaz AG; Pazarín-Villaseñor L; Yanowsky-Escatell FG; Andrade-Sierra J
    J Diabetes Res; 2016; 2016():7047238. PubMed ID: 27525285
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current practices in the management of diabetic nephropathy.
    Chan G; Tang SC
    J R Coll Physicians Edinb; 2013; 43(4):330-2; quiz 333. PubMed ID: 24350318
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Albuminuria and diabetic nephropathy.
    Chang SS
    Pediatr Endocrinol Rev; 2008 Aug; 5 Suppl 4():974-9. PubMed ID: 18806713
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.